Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial
Source: View publication →
This landmark international multicenter randomized trial demonstrated that a policy of planned cesarean section, compared to a policy of planned vaginal birth, significantly reduces perinatal and neonatal mortality and serious neonatal morbidity in singleton term breech pregnancies.
Key Findings
Study Design
Study Limitations
Clinical Significance
The publication of this trial led to a paradigm shift in obstetric practice globally, resulting in a dramatic increase in planned cesarean delivery rates for term breech presentations and a significant decline in the practice of vaginal breech birth in many developed nations.
Historical Context
Prior to this trial, management of term breech presentation was controversial and varied widely, with observational data suggesting potential risks to vaginal breech delivery but lacking high-level evidence from randomized controlled trials.
Guided Discussion
High-yield insights from every perspective
In the context of term breech presentation, why is the 'after-coming head' considered a primary mechanical risk during a vaginal delivery compared to a cephalic presentation?
Key Response
In a cephalic birth, the largest part of the fetus (the head) dilates the cervix first. In a breech birth, the smaller buttocks or feet may pass through a partially dilated cervix, but the larger, non-malleable head can become trapped (head entrapment) or lead to umbilical cord compression between the head and the pelvic rim, causing acute fetal hypoxia.
Following the publication of the Term Breech Trial, many departments moved toward universal elective cesarean for breech. However, if a patient insists on a trial of labor, what specific fetal and maternal criteria must be met to minimize morbidity according to modern obstetric standards?
Key Response
Modern criteria for a safe trial of breech labor include: frank or complete breech (not footling), fetal weight between 2500g and 4000g, absence of fetal head hyperextension on ultrasound, a 'favorable' maternal pelvis, and the presence of a clinician experienced in breech maneuvers.
How does the 2-year follow-up data from the Term Breech Trial participants complicate the initial recommendation for universal cesarean section, and how should this be integrated into patient counseling?
Key Response
While the initial 2000 study showed a significant reduction in short-term neonatal morbidity, the 2-year follow-up (Whyte et al., 2004) found no significant difference in the risk of death or neurodevelopmental delay between the two groups. This suggests that many of the acute morbidities captured in the initial study did not result in long-term permanent disability, which is a critical distinction when counseling patients on risk.
Considering the 'skill-rot' phenomenon that followed the Term Breech Trial, what strategies should academic departments implement to ensure that the next generation of providers can safely manage an unavoidable or precipitous breech delivery?
Key Response
Since elective cesarean has become the norm, residents have fewer opportunities for hands-on experience. This necessitates high-fidelity simulation training, the use of pelvic models for maneuvers like Bracht or Mauriceau-Smellie-Veit, and potentially identifying 'breech teams' or centers of excellence where low-risk vaginal breech births are still performed and taught.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
The Term Breech Trial was criticized for its use of a composite primary outcome. What are the methodological implications of combining rare events like perinatal mortality with more common events like transient brachial plexus injury or bone fractures in a single effect estimate?
Key Response
Composite outcomes can be dominated by the most frequent, least severe components, potentially masking the true effect on the most critical endpoints (mortality). If the treatment effect is inconsistent across the components of the composite, the resulting 'relative risk reduction' can be misleadingly high or fail to reflect the clinical utility of the intervention for life-threatening events.
As a reviewer, how would you evaluate the external validity of the Term Breech Trial given that nearly 33% of the participating centers were in developing countries with different standards of intrapartum monitoring and neonatal intensive care access?
Key Response
The benefit of planned cesarean was much more pronounced in 'high national perinatal mortality rate' countries than in 'low' rate countries. A critical reviewer would flag that applying these results universally to high-resource settings—where monitoring and rescue are more robust—might overestimate the safety benefit of cesarean sections in those specific environments, as seen later in the PREMODA study.
How do current ACOG and RCOG guidelines balance the findings of the Term Breech Trial with the subsequent PREMODA study when determining the Level of Evidence for planned vaginal breech delivery?
Key Response
ACOG Committee Opinion 745 and RCOG Green-top Guideline 20b acknowledge the Term Breech Trial but allow for planned vaginal delivery in selected cases. RCOG specifically notes that with strict selection criteria and experienced staff (as demonstrated in the PREMODA study), the perinatal mortality rate of vaginal breech delivery may approach that of cephalic presentation, moving the recommendation from a strict 'C-section only' to a 'shared decision-making' model (Level B/C evidence).
Clinical Landscape
Noteworthy Related Trials
PREMODA Study
Tested
Planned vaginal delivery for breech presentation
Population
Women with singleton breech presentation at term
Comparator
Planned cesarean section
Endpoint
Perinatal mortality and serious neonatal morbidity
Twin Birth Study
Tested
Planned cesarean section for twin delivery
Population
Women with twins at 32-38 weeks gestation
Comparator
Planned vaginal delivery
Endpoint
Composite of fetal or neonatal death or serious neonatal morbidity
PROBSTAT Study
Tested
Planned vaginal delivery with strict criteria
Population
Women with breech presentation at term
Comparator
Planned cesarean section
Endpoint
Composite of perinatal mortality and serious neonatal morbidity
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis